Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005-2009 and a comparison with those treated in 1985-2004. (Q46459281)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 December 2013

Language	Label	Description	Also known as
English	Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005-2009 and a comparison with those treated in 1985-2004.	scientific article published on 3 December 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005-2009 and a comparison with those treated in 1985-2004. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

1

object named as

Yuta Shibamoto

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

author name string

Minako Sumi

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Shunsuke Onodera

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Haruo Matsushita

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Chikao Sugie

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Yukihisa Tamaki

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Hiroshi Onishi

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Eisuke Abe

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Masahiko Koizumi

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Daisuke Miyawaki

10

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Seiji Kubota

11

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Etsuyo Ogo

12

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Takuma Nomiya

13

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Mitsuhiro Takemoto

14

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Hideyuki Harada

15

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Ippei Takahashi

16

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Yoshio Ohmori

17

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Naoya Ishibashi

18

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Sunao Tokumaru

19

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Kazunori Suzuki

20

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

publication date

3 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

International Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

19

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

963-971

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Primary central nervous system lymphoma: a curable brain tumor.

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Primary central nervous system lymphoma: biological aspects and controversies in management

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Current management of primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Pathogenesis and management of primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004.

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Primary central nervous system lymphoma: age and performance status are more important than treatment modality

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Surgery for primary CNS lymphoma? Challenging a paradigm

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Soluble interleukin-2 receptor in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

On the role of sIL-2R measurements in rheumatoid arthritis and cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0644-4

21 January 2018

Primary central nervous system lymphoma in Japan: a nationwide survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297187

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary CNS lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297187

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297187

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of primary central nervous system lymphoma treated by radiation and chemotherapy: retrospective analysis of twelve institutions in the Tokai District of Japan, 1995-1999

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297187

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary CNS lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297187

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary central nervous system lymphoma in Japan 1995-1999: changes from the preceding 10 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297187

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10147-013-0644-4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24297187

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46459281&oldid=2207880976"